A new computational method to unbiasedly predict I/S cells in cancer transcriptomics data.
We develop a semisupervised deconvolution method to handle the three challenges, with the following four steps: (1) Construct an ordering matrix to represent cell type specific gene expressions. We have collected large amount of gene expression data for fibroblast, adipocytes, endothelial, neuron, B cell, CD4+ T cell, CD8+ T cell, natural killer cell, dendritic cell, monocytes, macrophages, and neutrophils, all measured by Affymetrix U133 plus 2.0 array, totaling 387, 26, 606, 243, 404, 443, 130, 141, 410, 477, 277 , 257 samples, respectively. We utilized COMBAT [7] to remove the batch effect across datasets. Using these as training data, we constructed an ordering matrix by comparing a gene expression's expression among different cell type. The ordering matrix ‫ܮ‬ ୫ ൈ ୩
is takes value in the set is the relative proportion of cell type ݇ across all the N samples. This shows that genes uniquely expressed by a cell type forms a (matrix) rank-1 submatrix spanned by the vector of relative proportion of the cell type. To find such rank-1 submatrices in the whole matrix, we particularly realize that the level of co-expressions among a certain cell type's uniquely expressed genes are generally higher than their co-expression correlations with other genes, thus, we turn to find those strong co-expression modules using our in-house non-parametric network analysis method MRHCA [8, 9] , wherein the rank of the module could be determined by Bi-Cross Validation (BCV) rank test [10]( Figure  XB) . Expression of the genes coming from cancer cells will be eliminated by projecting X ൈ to the complementary space of the row space spanned by the cancer genes' modules, under which the rank structure of the I/S gene expressions will not change. Further, cell type of each identified rank-1 module will be annotated by the labeling matrix. (3) Infer the number of cell types and their expressed genes via a graph partition method. Genes in rank-1 modules identified in (2) can be either genes uniquely expressed in one cell type or genes with similar expression patterns in multiple cell types. To determine the number of cell types, we sequentially examine the combinations of 2, 3, and 4 rank-1 modules and re-calculate the rank of the newly combined modules. The searched modules will be linked to each other if the rank of their merged expression matrix is smaller than the number of unconnected parts among them. Such a process will link the rank-1 modules of genes expressed in multiple cell types with the modules of uniquely expressed genes of the cell types and eliminate the redundant rank of such modules. Then the total number of cell types covered by the
modules is determined by the sum of the rank of each disconnected subgraph in the linking graph ( Figure XC) . I/S cell types correspond to each disconnected subgraph will be annotated by the labeling matrix. (4) Predict cell type proportions using constrained NMF. We recently developed an algorithm to identify cell type unique modules in each disconnected subgraph, by which a constraint matrix C ൈ 
The advantages of this deconvolution method includes: (1) cell types and their uniquely expressed genes, instead of pre-defined, are specifically identified to the cancer microenvironment hidden in the dataset; (2) I/S proportions could be estimated free of batch effect by a NMF approach; (3) I/S co-infiltrations could be properly handled by the existence of cell type uniquely expressed genes that place the co-infiltrated cell types in disconnected subgraphs; and (4) commonly expressed genes in multiple cell types could be properly incorporated in a constrained NMF without harming the uniqueness of the solution. It is noteworthy the cell types are defined here as a combination of certain rank-1 markers, which may correspond to more than one commonly defined cell types by hematopoiesis lineage, namely, general T cell, total T and B cell, MHC class II antigen presenting cells, etc. This novel definition is entirely data-driven, without compromising the capacity of performing correlation analysis with features derived from genomics and imaging data, and most importantly, novel I/S sub cell types specific to a cancer micro-environment could be conveniently identified.
We have validated the method on six scRNA-seq simulated bulk tumor data sets of melanoma (MLN), head and neck cancer (HNC), colorectal cancer (CRC), breast cancer (BRC), glioma (ODG) and IDH-mutant astrocytoma (ATC) [12] [13] [14] . On average, our method achieves 0.92 correlation between the predicted and true cell proportions, and 0.958 R ଶ in fitting the I/S uniquely expressed genes. Overall, ICTD outperformed the prediction by EPIC, TIMER and CIBEROSRT. Specifically, EPIC achieved a good performance in prediction of macrophage and fibroblast cells, but the predicted B cell and T cell proportion has only a ~0.85 correlation with the true proportion, especially in the colorectal and breast cancer set. Timer has a good performance in prediction of T cell proportional but have a relative less prediction accuracy for B and Macrophage cells. Meanwhile, CIBERSORT has achieved less than 0.6 correlation between the predicted and true cell proportions, and only 0.45 R ଶ in the fitting of marker genes (Figure 2 ). In addition, the method can effectively identify novel sub cell types within the pre-identified cell classes, such as sub fibroblast and myeloid cell types, as well as the cell types not covered by the training data, namely Mast and Myocyte cell in the HNC, Schwann cells in the ODG and Microglial cells in the ATC and ODG data.
We applied our deconvolution method to two TNBC RNA-Seq data sets, one in TCGA and another in IUSM, and six microarray data sets retrieved from public domain, totaling 851 samples. Our analysis identified 29, 12, 16, 36, 8, 32, 9 , and 12 uniquely expressed marker genes corresponding to T-, B-, macrophage, neutrophil, dendritic, fibroblast, adipocyte, and endothelial cells respectively that are consistent in all data sets (consistent markers are shown in Table 1 ). On average, our method achieves 0.87 by feeding these consistent markers to our NMF algorithm, comparing to 0.32 by CIBERSORT which uses SVM regression analysis based on a set of pre-defined genes. In addition, TCGA cohort has morphological data lymphocyte infiltration levels for all samples with pathological images, and our predicted T cell infiltratio has a Spearman correlation of 0.53 with the imaging-derived lymphocyte infiltration level in TNBC data the correlation is 0.3 for CIBERSORT predicted TILs [15] ; We expect the analysis on the large am TNBC samples will generate robust gene markers and infiltration level of TILs.
ICTD is also applied to TCGA colorectal and breast cancer to compare with EPIC, TIMER and CIBERSO real cancer data. Specifically, we developed a goodness of fitting score for each gene by the of negative regression of the gene expression by the predicted cell proportions. The advantage of this s that the bias of the gene expression signature of different methods are eliminated in the analysis, and evaluation of the predicted immune cell proportion enables the comparison between our semi-sup method with the three supervised methods. The goodness of fitting clearly suggested the proportions pr by ICTD significantly better explains the expression of each gene (with an averaged >0.6) than th three methods. low rank submatrix and our recent analysis on TNBC samples indicates that in samples with high infiltration, the T cell cytotoxicity and infiltration marker genes form two distinct 1-rank modules, w samples with low T cell infiltration, they only form one 1-rank module (Figure 3) . Clearly, varied cytotox samples with high T cell infiltration is of more interest, hence we propose to identify functional activity le detecting the 1-or low rank structure in samples with high infiltration levels, i.e. a local low rank structur Denote as predicted proportion of cell type k for the n samples and as sorted by increasing order, as the rank-1 marker genes of cell type k, and is a ge containing marker genes of a varied function of k, then the level of functional activity and its associated genes can be identified by the following algorithm using BCV tests. The expected results of this a include gene markers that form a local low rank structure specifically in the samples with high infiltratio I/S cell type, which corresponds to a varied immune functional activity, and the activity level can be pr by the aforementioned NMF approach. ( 1 ) . 8 
